Hinge Health, Inc. Class A Common Stock (HNGE)

Deferred Revenue

$416.47M

Quarterly · Period ending: · USD

HNGE logo

HNGE Deferred Revenue

Latest reported$416.47M
HNGE Quarterly Deferred Revenue ($217.63M → $416.47M)
High-resolution chart · PNG

HNGE deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Hinge Health, Inc. Class A Common Stock Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
416,466,000
340,766,000
300,855,000
299,695,000
275,138,000
217,328,000
217,632,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.